DOI:
https://doi.org/10.20882/adicciones.536Palabras clave:
Resumen
Citas
(1) Buschbaum DG, Buchanan RG, Poses RM, Schnoll SH, Lawton MJ. Physician detection of drinking problems in patients attending a general medical practice. J Gen Intern Med. 1992;7:517-521.
(2) Cirera E y cols. Alcoholismo en el Hospital General. Med. Clin 1985;85: 96-98.
(3) Michael F. Mayo-Smith, MD, MPH; for the American Society of Addiction Medicine Working Group on Pharmacological Management of Alcohol Withdrawal. Pharmacological Management of Alcohol Withdrawal. Jama 1997;144-151.
(4) Victor M., Adams R. The effect of alcohol on the nervous system. Research publication of the Association for Nervous and Mental Disorders.
; 32:526-573.
(5) Stockwell T, Sitharthan T, McGrath D. The measurement of alcohol dependence and impaired control in the general population. Addiction 1994; 89: 167-174.
(6) Foy A, Kay J. The incidence of alcohol-related problems and the risk of alcohol withdrawal in a general hospital population. Drug Alcohol Rev. 1995; 14:49-54.
(7) Nevo I, Hamon M. Neurotransmitter and neuromodulatory mechanisms involved in alcohol abuse and alcoholism. Neurochem Int 1995;26,4:305-306.
(8) Kumari M. Ticku MK. Regulation of NMDA receptors by ethanol. Progress in Drug Research. 2000;54:152-189.
(9) Casas M, Prat G, Guardia J. Los efectos del etanol sobre el sistema de neurotransmisión dopaminérgico como posible sustrato biológico de los trastornos psíquicos observados en el alcoholismo. En: Casas M, Gutiérrez M, San L. Psicopatología y alcoholismo. Ediciones en Neurociencias. Barcelona, 1994.
(10) Heinz A, Scmidt K, Baumm SS. Influence of dopaminergic transmission on severity of withdrawal syndrome in alcoholism. J Stud
Alcohol 1996; 57:471-474.
(11) Ballenger J.C., Post R.M. kindling as a model for the alcohl withdrawal syndromes. Br. J. Psychiatry. 1978;133:1-14.
(12) Hundt W. Zimmermann U. Potting M. Spring K. Holsboer F. The combined dexamethasonesuppresion/crh-stimulation test in alcoholics
during and after acute withdrawal. Alcoholism: Clinical and Experimental Research. 2001;25 (5):687-691.
(13) Nutt D, Adinoff B. Linnoila M. Benzodiacepines in the treatment of alcoholism. In Recent Development in Alcoholism. Galanter M. ed.
; pp:283-313.
(14) Soler Insa P.A., Sanahuja Solans J., Mengual Prims A. Trastornos mentales y del comportamiento debidos al consumo de alcohol. Tratado
de psiquiatría. Editor: Barcia Salorio. 2000;pp 221-242.
(15) Guerola J, Martínez C. Urgencias médicas originadas por el consumo de alcohol. Tratado de Alcohología. Ed.:Cuevas J y Sanchís M. 2000. pp.: 305-357.
(16) Ferguson JA, Suelzer CJ, Eckert GJ. Risk factors for delirium tremens development. J Gen Intern Med 1996; 11: 410-414.
(17) Williams D, Lewis J, McBride Andrew. A comparison of rating scales for the alcohol withdrawal syndrome. Alcohol and Alcoholism. 2001. Vol 36, No 2, pp:104-108.
(18) Hugh Myrick, MD, Raymond F. Anton, MD. Clinical Management of Alcohol Withdrawal. CNS Spectrums 2000;5(2):22-23.
(19) Saitz R, O’Malley SS. Pharmacotherapies of alcohol abuse: withdrawal and treatment. Med Clin North Am. 1997;81:881-907.
(20) G.K. Shaw, S. Waller, C.J. Latham, G. Dunn, A.D. Thomson. The detoxification experience of alcoholic in-patients and predictors of
outcome. Alcohol and alcoholism. 1998. Vol. 33. NO.3,pp:291-303.
(21) Abbot JA, Quinn D, Knox L. Ambulatory medical detoxification for alcohol. Am J Drug Alcohol Abuse. 1995;21:549-563.
(22) Hyashida M, Alterman AI, McClellan AT, et al: Comparative effectivenes and costs of inpatient and oupatient detoxification of
patients with mild to moderate withdrawal syndrome. N Eng J Med. 1989;320:358-365.
(23) Pattison Me: Management of alcoholism in medical practice. Med Clin North Am. 1977;61:797-809.
(24) Withfield CL: Nondrug detoxification in Phenomenology and Treatment of Alcoholism. Withfield C. New York, Spectrum Press. 1980.
(25) Gallant DM: Reduction of ethanol intake by pharmacologic agents-investigational problems. Alcohol Clin Exp Res. 1992;16:472-473.
(26) Shaw JM, Kolesar GS, Sellers EM, Kaplan HL, Sandors P. Development of optimal treatment tactics for alcohol withdrawal, Y: assesment and effectiveness of supportive care. J Clin Psychopharmacol. 1981;382-387.
(27) Myrick Hugh, MD, Anton RF, MD. Clinical Management of Alchol withdrawal. CNS Spectrums 2000;5(2):22-32.
(28) Glatt, M., George, H.R., Frisch, E.P. Controlled study of chlormethiazole in treatment of the alcohol withdrawal phase. British Medical Journal.1965;2:401-404.
(29) Lejoyeux Michel, Solomon Jacquelyn, Adès Jean. Benzodiazepine Treatment for alcoholdependent patients. Review. Alcohol and
alcoholism. 1998; 33:563-575.
(30) Institute of Medicine. Prevention and Treatment of Alcohol Problems. Washington, DC: National Academy Press; 1990:268-269.
(31) Moskowitz G, Chalmers TC, Sacks HS, Fagerstrom RM, Smith H. Deficiencies of clinical trials of alcohol withdrawal. Alcohol Clin Exp Res. 1983;7:42-46.
(32) Ozdemir V, Bremmer KE, Naranjo CA. Treatment of alcohol withdrawal syndrome. Trends in Clinical Practice. Anals of Medicine.
;26:101-105.
(33) Sellers EM, Naranjo CA, Harrison M, Devenyl P, Roach C, Sykora K. Diacepam loading: simplified treatment of alcohol withdrawal. Clin
Pharmacol Ther. 1983;34:822-826.
(34) Adinoff B. Double blind study of alprazolam, diacepam, clonidine and placebo in the alcohol withdrawal syndrome: preliminary findings.
Alcohol Clin Exp Res. 1995;18:873-878.
(35) Borg S., Carlsson S., Lafolie P. Benzodiazepine/ alcohol dependence and abuse. Benzodiazepine Dependence, Hallström,C.ed. 1993, pp:119-127.
(36) Gallant DM. Improvements in treatment of alcohol withdrawal syndromes. Alcohol Clin Exp Res. 1989;13:721-722.
(37) Rojo Rodes J.E., Cirera Costa E. Interconsulta psiquiátrica. Ed. Masson. 1977,pp:539-545.
(38) Wartenberg AA, Nirenberg TD, Liepman MR, Silvia LY, Begin AM, Monti PM. Detoxification of alcoholics:improving care by symptomtriggered
sedation. Alcohol Clin Exp Res. 1990;14:71-75.
(39) Sullivan JT, Swift RM, Lewis DC. Benzodiazepine requierements during alcohol withdrawal syndrome: clinical implications of using a
standarized withdrawal scale. J Clin Psychopharmacol. 1991; 11:291-295.S
(40) Saitz R, Mayo-Smith MF, Robers MS, Redmond HA, Bernard DR, Calkins DR. Individualized treatment for alcohol withdrawal: a randomized
double-blind controlled trial. JAMA. 1994;272:519-523.
(41) Bjorkquist SE, Isohanni M, Makella R, Malinen L. Ambulant treatment of alcohol withdrawal symptoms with carbamazepine: a formal
multicentre double-blind comparison with placebo Acta Psychiatr Scand. 1976;53:333-342.
(42) Brune, F., Busch, H. Anticonvulsivant-sedative treatment of delirium alcoholism. Quarterly Journal of Studies on alcohol. 1971;32:334-342.
(43) Ballenger JC, Post RM. kindling as a model for the alcohol withdrawal syndrome. Br J Psychiatry. 1978;133:1-4.
(44) Butler, D., Messiah, F.S. Alcohol withdrawal and carbamazepine. 1986;3:113-129.
(45) Ketter, T.A., Post, R.M., Worhington K. Principles of clinically important drug interactions with carbamacepina. Journal of Clinical Psycopharmacology. 1991;11:19-203.
(46) Malcolm R. Myrick H. Brady KT. Ballenger JC. Update on anticonvulsivants for the treatment of alcohol withdrawal. American Journal on Addictions. 2001, 10 Suppl:16-23.
(47) Bjorkvist, S.E. Clonidine in alcohol withdrawal. Acta Psychiatrica Scandinavica. 1975;52:256-263.
(48) Baumgartner GR, Rowen RC. Clonideine vs chlordiazepoxide in the management of acute alcohol withdrawal syndrome. Arch Intern
Med. 1987;147:1223-1226.
(49) Zilm DH, Jacob MS, Mac Leod SM, Sellers EM, Ti TY. Propranolol and chlordiazepoxide effects on cardiac arrhytmias during alcohol withdrawal. Alcohol Clin Exp Res. 1980;4:400-405.
(50) Kraus ML, Gottlieb LD, Horwitz RI, Anscher M. Randomized clinical trial of atenolol in patients with alcohol withdrawal. N Engl J Med. 1985;
:905-910.
(51) Wilson A, Vulcano B. A double-blind placebocontrolled trial of magnesium sulfate in the ethanol withdrawal syndrome. Alcohol Clin Exp
Res. 1984;8:542-545.
(52) Sellers, EM. Cooper, SD. Zilm DH. Shanks C. Lithium treatment during alcohol withdrawal. Clinical Pharmacology and Therapy. 1976;20:
-206.
(53) Borg, V. Weinholt, T. Bromocriptine in the treatment of alcohol withdrawal syndrome. Acta Psychiatrica Scandinavica. 1982;65:101-111.
(54) Burroughs AK, Morgan MY, Sherlock S. Double blind controlled trial of bromocriptine, chlordiazepoxide and chlormetiazole for alcohol withdrawal symptoms. Alcohol and alcoholism. 1985; 20:263-271.
(55) Gallimberti, L., Canton, G., Gentile, N., Ferri, M., Cibin, M., Ferrara, S.D., Fadda, F. and Gessa, G.L. Gamma-hydroxy-butyric acid for treatment of alcohol withdrawal syndrom. Lancet. 1989 ii,787-789.
(56) Roy-Byrne PP, Ward NG, Donnell PJ. Valproate in anxiety and withdrawal syndromes. J. Clin. Psychiatry. 1989; 50: 44-48.
(57) Thompson MD. Gonzalez N. Nguyen T. Comings DE. George SR. O’Dowd BF. Serotonin transporter gene polymorphisms in alcohol dependence. Alcohol. 2000;22:61-67.
(58) Palmstierna T. A model for predicting alcohol withdrawal delirium. Psychiatric Services. 2001;52:820-823.
(59) Ahmed S, Chadwick D, Walker RJ. The management of alcohol related seizures: an overview. Hosp Med 2000 Nov;61:793-796.
(60) Tilman Wetterling, Martin Driessen, Rolf-Dieter Kanitz, Klaus Junghanns. The severity of alcohol withdrawal is not age dependent.
Alcohol and Alcoholism. Vol 36, No 1, pp. 75-78, 2001.
(61) Spies CD, Rommelspacher H. Alcohol withdrawal in the surgical patient: prevention and treatment. Anesth Analg 1999 Apr;88(4):
-954.
(62) Soler PA, Gascón J. Protocolos de terapéutica psiquiátrica. 1995. pp: 157-164.
(63) Soler PA, Gascon J. Recomendaciones terapéuticas en los trastornos mentales. De Masson. 1999. pp:11-25.
(64) Shaw,GK. Detoxification: the use of benzodiazepines. Alcohol and Alcoholism. 1995;30:765-770.



